Physician profile
John M Bell
NPI 1124094115
$1,537.21
in general payments reported to CMS, 2019-2025
16 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $53.97 · 2021: $392 · 2022: $140 · 2023: $165 · 2024: $176 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.17 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Cameron-Ehlen Group, INC. | $301.50 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $290.86 | 2019-2021 | |
| Ellexiscience | $181.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $157.89 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $135.14 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $113.30 | 2021-2025 | Tryptyr, Clareon |
| Harrow Eye, LLC | $89.45 | 2024-2025 | Vevye |
| Amgen INC. | $51.59 | 2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $44.94 | 2021-2022 | |
| Abbvie INC. | $35.85 | 2022-2024 | |
| Shire North American Group INC | $35.29 | 2019 | |
| Abb Con-Cise Optical Group LLC | $28.66 | 2020 | |
| Eyevance Pharmaceuticals LLC | $19.02 | 2021 | |
| Astellas Pharma US INC | $18.87 | 2024 | Izervay |
| Dompe US, INC. | $17.27 | 2025 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $16.57 | 2025 | Tyrvaya, Ryzumvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.